NZ_CP009512.1_orf46082	38ac5a15a089f553c218fcf03b349ce0	1536	CDD	cd14254	Dockerin_II	1480	1532	1.07585E-13	T	24-06-2023	-	-
NZ_CP009512.1_orf46082	38ac5a15a089f553c218fcf03b349ce0	1536	ProSiteProfiles	PS51766	Dockerin domain profile.	1475	1536	11.445045	T	24-06-2023	IPR016134	Dockerin domain
NZ_CP009512.1_orf46082	38ac5a15a089f553c218fcf03b349ce0	1536	Pfam	PF05345	Putative Ig domain	1308	1384	2.4E-10	T	24-06-2023	-	-
NZ_CP009512.1_orf46082	38ac5a15a089f553c218fcf03b349ce0	1536	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	1389	1477	8.9E-6	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf46082	38ac5a15a089f553c218fcf03b349ce0	1536	ProSitePatterns	PS00018	EF-hand calcium-binding domain.	1512	1524	-	T	24-06-2023	IPR018247	EF-Hand 1, calcium-binding site
NZ_CP009512.1_orf46082	38ac5a15a089f553c218fcf03b349ce0	1536	SUPERFAMILY	SSF49313	Cadherin-like	1317	1388	8.32E-9	T	24-06-2023	IPR015919	Cadherin-like superfamily
NZ_CP009512.1_orf46082	38ac5a15a089f553c218fcf03b349ce0	1536	Pfam	PF00404	Dockerin type I domain	1480	1528	6.7E-9	T	24-06-2023	IPR002105	Dockerin type I repeat
NZ_CP009512.1_orf46082	38ac5a15a089f553c218fcf03b349ce0	1536	Gene3D	G3DSA:1.10.1330.10	Dockerin domain	1478	1536	9.8E-13	T	24-06-2023	IPR036439	Dockerin domain superfamily
NZ_CP009512.1_orf46082	38ac5a15a089f553c218fcf03b349ce0	1536	Gene3D	G3DSA:2.60.40.680	-	1161	1293	8.0E-9	T	24-06-2023	-	-
NZ_CP009512.1_orf46082	38ac5a15a089f553c218fcf03b349ce0	1536	ProSitePatterns	PS00018	EF-hand calcium-binding domain.	1481	1493	-	T	24-06-2023	IPR018247	EF-Hand 1, calcium-binding site
NZ_CP009512.1_orf46082	38ac5a15a089f553c218fcf03b349ce0	1536	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	1296	1385	1.1E-14	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf46082	38ac5a15a089f553c218fcf03b349ce0	1536	SUPERFAMILY	SSF63446	Type I dockerin domain	1480	1532	2.94E-8	T	24-06-2023	IPR036439	Dockerin domain superfamily
NZ_CP009512.1_orf46082	38ac5a15a089f553c218fcf03b349ce0	1536	CDD	cd08547	Type_II_cohesin	1159	1298	2.14288E-7	T	24-06-2023	-	-
NZ_CP009512.1_orf46082	38ac5a15a089f553c218fcf03b349ce0	1536	SUPERFAMILY	SSF49384	Carbohydrate-binding domain	1169	1295	5.23E-8	T	24-06-2023	IPR008965	CBM2/CBM3, carbohydrate-binding domain superfamily
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SUPERFAMILY	SSF49299	PKD domain	1097	1176	4.58E-24	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	394	453	18.044901	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	795	841	14.992101	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Pfam	PF02239	Cytochrome D1 heme domain	510	611	2.6E-6	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SUPERFAMILY	SSF49299	PKD domain	1011	1091	8.5E-27	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	FunFam	G3DSA:2.60.40.10:FF:000270	Cell surface protein	1614	1694	1.7E-27	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SUPERFAMILY	SSF50974	Nitrous oxide reductase, N-terminal domain	44	359	1.44E-79	T	24-06-2023	IPR011045	Nitrous oxide reductase, N-terminal
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SUPERFAMILY	SSF49299	PKD domain	1273	1356	6.8E-27	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	1363	1446	22.364901	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Pfam	PF18911	PKD domain	1448	1525	5.7E-15	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Pfam	PF18911	PKD domain	1196	1257	1.5E-16	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Pfam	PF18911	PKD domain	762	841	4.4E-14	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Pfam	PF18911	PKD domain	1626	1692	1.8E-15	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Pfam	PF18911	PKD domain	855	916	3.7E-15	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Pfam	PF18911	PKD domain	1545	1610	3.5E-16	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Pfam	PF18911	PKD domain	1375	1441	1.4E-17	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Pfam	PF18911	PKD domain	1290	1354	7.4E-18	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Pfam	PF18911	PKD domain	1110	1171	1.3E-13	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Pfam	PF18911	PKD domain	1022	1091	4.5E-16	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Pfam	PF18911	PKD domain	938	1005	2.5E-18	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Pfam	PF18911	PKD domain	365	446	8.1E-18	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Gene3D	G3DSA:2.130.10.10	-	552	760	3.5E-70	T	24-06-2023	IPR015943	WD40/YVTN repeat-like-containing domain superfamily
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Gene3D	G3DSA:2.130.10.10	-	65	365	6.7E-138	T	24-06-2023	IPR015943	WD40/YVTN repeat-like-containing domain superfamily
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	FunFam	G3DSA:2.60.40.10:FF:000270	Cell surface protein	843	922	1.4E-22	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	TIGRFAM	TIGR02276	beta_rpt_yvtn: 40-residue YVTN family beta-propeller repeat	455	493	2.1E-7	T	24-06-2023	IPR011964	YVTN beta-propeller repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	TIGRFAM	TIGR02276	beta_rpt_yvtn: 40-residue YVTN family beta-propeller repeat	273	316	2.7E-10	T	24-06-2023	IPR011964	YVTN beta-propeller repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	TIGRFAM	TIGR02276	beta_rpt_yvtn: 40-residue YVTN family beta-propeller repeat	626	666	1.3E-14	T	24-06-2023	IPR011964	YVTN beta-propeller repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	TIGRFAM	TIGR02276	beta_rpt_yvtn: 40-residue YVTN family beta-propeller repeat	317	353	7.8E-13	T	24-06-2023	IPR011964	YVTN beta-propeller repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	TIGRFAM	TIGR02276	beta_rpt_yvtn: 40-residue YVTN family beta-propeller repeat	231	272	2.1E-14	T	24-06-2023	IPR011964	YVTN beta-propeller repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	TIGRFAM	TIGR02276	beta_rpt_yvtn: 40-residue YVTN family beta-propeller repeat	709	749	5.0E-9	T	24-06-2023	IPR011964	YVTN beta-propeller repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	TIGRFAM	TIGR02276	beta_rpt_yvtn: 40-residue YVTN family beta-propeller repeat	69	104	7.2E-13	T	24-06-2023	IPR011964	YVTN beta-propeller repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	TIGRFAM	TIGR02276	beta_rpt_yvtn: 40-residue YVTN family beta-propeller repeat	105	146	1.5E-18	T	24-06-2023	IPR011964	YVTN beta-propeller repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	TIGRFAM	TIGR02276	beta_rpt_yvtn: 40-residue YVTN family beta-propeller repeat	667	708	1.2E-17	T	24-06-2023	IPR011964	YVTN beta-propeller repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	TIGRFAM	TIGR02276	beta_rpt_yvtn: 40-residue YVTN family beta-propeller repeat	189	230	2.9E-14	T	24-06-2023	IPR011964	YVTN beta-propeller repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	TIGRFAM	TIGR02276	beta_rpt_yvtn: 40-residue YVTN family beta-propeller repeat	583	624	1.2E-16	T	24-06-2023	IPR011964	YVTN beta-propeller repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	TIGRFAM	TIGR02276	beta_rpt_yvtn: 40-residue YVTN family beta-propeller repeat	147	188	2.6E-14	T	24-06-2023	IPR011964	YVTN beta-propeller repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	TIGRFAM	TIGR02276	beta_rpt_yvtn: 40-residue YVTN family beta-propeller repeat	541	582	1.1E-14	T	24-06-2023	IPR011964	YVTN beta-propeller repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	CDD	cd00146	PKD	1013	1091	2.69393E-11	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SUPERFAMILY	SSF49299	PKD domain	1614	1693	1.09E-24	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	CDD	cd00146	PKD	1448	1526	3.43864E-11	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	FunFam	G3DSA:2.60.40.10:FF:000270	Cell surface protein	367	449	1.4E-26	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SUPERFAMILY	SSF49299	PKD domain	1182	1262	1.83E-25	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	FunFam	G3DSA:2.60.40.10:FF:000270	Cell surface protein	926	1007	7.3E-31	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	CDD	cd00146	PKD	387	446	7.93196E-9	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	1096	1174	2.0E-22	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	1276	1355	4.5E-24	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	926	1006	2.8E-26	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	845	919	4.6E-19	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	1182	1265	3.4E-23	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	1012	1091	2.4E-23	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	1531	1611	4.0E-23	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	1447	1526	2.9E-23	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	763	844	3.9E-24	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	1616	1692	5.7E-22	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	366	447	2.4E-25	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	843	926	18.601702	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	FunFam	G3DSA:2.60.40.10:FF:000270	Cell surface protein	1446	1527	1.9E-29	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	1533	1616	20.790501	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	CDD	cd00146	PKD	1278	1356	2.5632E-12	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SUPERFAMILY	SSF51004	C-terminal (heme d1) domain of cytochrome cd1-nitrite reductase	453	746	9.15E-73	T	24-06-2023	IPR011048	Cytochrome cd1-nitrite reductase-like, haem d1 domain superfamily
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SUPERFAMILY	SSF49299	PKD domain	1360	1441	9.42E-28	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	FunFam	G3DSA:2.60.40.10:FF:000270	Cell surface protein	1276	1357	1.8E-30	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Pfam	PF10282	Lactonase, 7-bladed beta-propeller	132	251	3.9E-7	T	24-06-2023	IPR019405	Lactonase, 7-bladed beta propeller
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	1278	1361	21.347301	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	1013	1096	18.755301	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	FunFam	G3DSA:2.60.40.10:FF:000270	Cell surface protein	1361	1442	2.4E-30	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SUPERFAMILY	SSF49299	PKD domain	845	921	9.29E-22	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	CDD	cd00146	PKD	1184	1262	1.15403E-10	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	1448	1531	18.486502	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	MobiDBLite	mobidb-lite	consensus disorder prediction	954	973	-	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SUPERFAMILY	SSF49299	PKD domain	335	447	3.79E-24	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	FunFam	G3DSA:2.60.40.10:FF:000270	Cell surface protein	764	842	7.1E-25	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	1184	1267	19.561701	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	1361	1446	9.4E-25	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	FunFam	G3DSA:2.60.40.10:FF:000270	Cell surface protein	1182	1263	9.9E-28	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	CDD	cd00146	PKD	1534	1611	1.91763E-10	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	CDD	cd00146	PKD	1363	1441	8.93828E-14	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	Gene3D	G3DSA:2.130.10.10	-	448	551	2.7E-28	T	24-06-2023	IPR015943	WD40/YVTN repeat-like-containing domain superfamily
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	PANTHER	PTHR47197	PROTEIN NIRF	3	432	0.0	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	CDD	cd00146	PKD	1098	1176	5.33579E-11	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	CDD	cd00146	PKD	852	921	2.14978E-8	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	1098	1176	18.5825	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	FunFam	G3DSA:2.60.40.10:FF:000270	Cell surface protein	1096	1177	6.3E-28	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SMART	SM00320	WD40_4	605	644	50.0	T	24-06-2023	IPR001680	WD40 repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SMART	SM00320	WD40_4	169	208	18.0	T	24-06-2023	IPR001680	WD40 repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SMART	SM00320	WD40_4	519	560	260.0	T	24-06-2023	IPR001680	WD40 repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SMART	SM00320	WD40_4	647	686	57.0	T	24-06-2023	IPR001680	WD40 repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SMART	SM00320	WD40_4	211	250	310.0	T	24-06-2023	IPR001680	WD40 repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SMART	SM00320	WD40_4	127	166	160.0	T	24-06-2023	IPR001680	WD40 repeat
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	FunFam	G3DSA:2.60.40.10:FF:000270	Cell surface protein	1531	1612	4.1E-29	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SUPERFAMILY	SSF49299	PKD domain	1532	1611	4.71E-26	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	FunFam	G3DSA:2.60.40.10:FF:000270	Cell surface protein	1011	1092	1.5E-27	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	1615	1695	19.657701	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SMART	SM00089	PKD_9	1185	1263	1.3E-22	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SMART	SM00089	PKD_9	1099	1177	1.7E-25	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SMART	SM00089	PKD_9	1534	1612	1.2E-24	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SMART	SM00089	PKD_9	1279	1357	6.8E-26	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SMART	SM00089	PKD_9	929	1007	2.4E-28	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SMART	SM00089	PKD_9	844	922	3.1E-18	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SMART	SM00089	PKD_9	1616	1694	8.0E-24	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SMART	SM00089	PKD_9	1364	1442	5.0E-29	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SMART	SM00089	PKD_9	1449	1527	2.4E-23	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SMART	SM00089	PKD_9	767	842	6.7E-20	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SMART	SM00089	PKD_9	1014	1092	2.6E-25	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SMART	SM00089	PKD_9	370	449	2.6E-26	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	CDD	cd00146	PKD	767	841	1.21944E-8	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	928	1011	21.6737	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	CDD	cd00146	PKD	928	1006	4.38421E-12	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SUPERFAMILY	SSF49299	PKD domain	1446	1526	1.31E-25	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	CDD	cd05819	NHL	485	722	1.33129E-26	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SUPERFAMILY	SSF49299	PKD domain	738	844	1.57E-24	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	CDD	cd00146	PKD	1615	1678	5.72613E-10	T	24-06-2023	-	-
NZ_CP009512.1_orf40047	14ca3d21f612dfbd642633dc2be9bcf9	1695	SUPERFAMILY	SSF49299	PKD domain	925	1006	7.06E-29	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf31062	212de94e0b7608dced9f38caf0fff882	1665	Coils	Coil	Coil	1369	1389	-	T	24-06-2023	-	-
NZ_CP009512.1_orf31062	212de94e0b7608dced9f38caf0fff882	1665	MobiDBLite	mobidb-lite	consensus disorder prediction	1530	1643	-	T	24-06-2023	-	-
NZ_CP009512.1_orf31062	212de94e0b7608dced9f38caf0fff882	1665	MobiDBLite	mobidb-lite	consensus disorder prediction	1530	1619	-	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	714	768	14.569701	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	1010	1090	4.4E-18	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	522	601	1.5E-21	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	602	682	1.6E-19	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	440	517	1.2E-20	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	845	925	1.6E-21	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	927	1007	8.1E-18	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	683	762	4.5E-19	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	765	842	4.4E-18	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	960	1011	13.974501	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	FunFam	G3DSA:2.60.40.10:FF:000270	Cell surface protein	522	602	8.4E-22	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	SMART	SM00089	PKD_9	525	602	1.4E-19	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	SMART	SM00089	PKD_9	1014	1093	2.2E-14	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	SMART	SM00089	PKD_9	443	521	4.0E-15	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	SMART	SM00089	PKD_9	687	764	1.4E-13	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	SMART	SM00089	PKD_9	849	926	1.8E-18	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	SMART	SM00089	PKD_9	606	683	2.2E-15	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	SMART	SM00089	PKD_9	930	1007	1.7E-12	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	SMART	SM00089	PKD_9	768	847	3.9E-16	T	24-06-2023	IPR022409	PKD/Chitinase domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	SMART	SM00634	big_1	340	427	2.5E-4	T	24-06-2023	IPR003344	Big-1 (bacterial Ig-like domain 1) domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	SUPERFAMILY	SSF49299	PKD domain	765	845	1.57E-18	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	CDD	cd00146	PKD	766	835	4.49593E-8	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	633	687	14.531301	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	TIGRFAM	TIGR04213	PGF_pre_PGF: PGF-pre-PGF domain	1323	1476	1.5E-31	T	24-06-2023	IPR026453	PGF-pre-PGF domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	SUPERFAMILY	SSF49299	PKD domain	684	768	1.03E-19	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	SUPERFAMILY	SSF49299	PKD domain	926	1008	4.84E-19	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	798	849	13.1681	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	SUPERFAMILY	SSF49299	PKD domain	434	521	6.15E-22	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	CDD	cd00146	PKD	605	677	8.29312E-7	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	CDD	cd00146	PKD	685	757	1.71664E-7	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	SUPERFAMILY	SSF49299	PKD domain	603	685	5.76E-20	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	CDD	cd00146	PKD	531	595	2.11772E-8	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	SUPERFAMILY	SSF49373	Invasin/intimin cell-adhesion fragments	343	419	2.16E-9	T	24-06-2023	IPR008964	Invasin/intimin cell-adhesion fragments
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	PANTHER	PTHR36842	PROTEIN TOLB HOMOLOG	1012	1090	5.8E-55	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	Pfam	PF02369	Bacterial Ig-like domain (group 1)	356	415	8.0E-9	T	24-06-2023	IPR003344	Big-1 (bacterial Ig-like domain 1) domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	1034	1081	11.555301	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	SUPERFAMILY	SSF49299	PKD domain	844	928	1.05E-22	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	CDD	cd00146	PKD	848	925	4.16906E-6	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	340	427	1.8E-9	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	876	930	15.164901	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	SUPERFAMILY	SSF49299	PKD domain	1005	1094	1.7E-20	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	Pfam	PF18911	PKD domain	604	667	3.9E-12	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	Pfam	PF18911	PKD domain	942	1000	2.2E-10	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	Pfam	PF18911	PKD domain	441	512	2.6E-12	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	Pfam	PF18911	PKD domain	698	756	3.9E-11	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	Pfam	PF18911	PKD domain	765	836	4.2E-11	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	Pfam	PF18911	PKD domain	530	599	5.3E-13	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	Pfam	PF18911	PKD domain	846	925	6.0E-13	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	550	606	15.740901	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	Pfam	PF00801	PKD domain	1018	1083	4.7E-8	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	SUPERFAMILY	SSF49299	PKD domain	523	603	8.11E-22	T	24-06-2023	IPR035986	PKD domain superfamily
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	CDD	cd00146	PKD	928	1001	1.70745E-5	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	FunFam	G3DSA:2.60.40.10:FF:000270	Cell surface protein	846	926	6.8E-22	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	CDD	cd00146	PKD	443	515	4.58472E-8	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	ProSiteProfiles	PS51127	Big-1 (bacterial Ig-like domain 1) domain profile.	340	435	24.955105	T	24-06-2023	IPR003344	Big-1 (bacterial Ig-like domain 1) domain
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	CDD	cd00146	PKD	1013	1083	3.42779E-6	T	24-06-2023	-	-
NZ_CP009512.1_orf70569	a7773cb9c8a6c72791d42313a1083fe0	1592	ProSiteProfiles	PS50093	Polycystic kidney disease (PKD) domain profile.	465	525	14.377701	T	24-06-2023	IPR000601	PKD domain
NZ_CP009512.1_orf64386	b3daada1756e28a5a72847430dc58f71	1532	SUPERFAMILY	SSF117074	Hypothetical protein PA1324	54	96	9.42E-7	T	24-06-2023	-	-
NZ_CP009512.1_orf64386	b3daada1756e28a5a72847430dc58f71	1532	PANTHER	PTHR44119	MAGNESIUM-CHELATASE SUBUNIT CHLH, CHLOROPLASTIC	143	1527	0.0	T	24-06-2023	IPR003672	CobN/magnesium chelatase
NZ_CP009512.1_orf64386	b3daada1756e28a5a72847430dc58f71	1532	MobiDBLite	mobidb-lite	consensus disorder prediction	1415	1480	-	T	24-06-2023	-	-
NZ_CP009512.1_orf64386	b3daada1756e28a5a72847430dc58f71	1532	MobiDBLite	mobidb-lite	consensus disorder prediction	1415	1432	-	T	24-06-2023	-	-
NZ_CP009512.1_orf64386	b3daada1756e28a5a72847430dc58f71	1532	Pfam	PF02514	CobN/Magnesium Chelatase	290	1364	0.0	T	24-06-2023	IPR003672	CobN/magnesium chelatase
NZ_CP009512.1_orf64386	b3daada1756e28a5a72847430dc58f71	1532	Gene3D	G3DSA:2.60.40.10	Immunoglobulins	28	132	6.1E-5	T	24-06-2023	IPR013783	Immunoglobulin-like fold
NZ_CP009512.1_orf64386	b3daada1756e28a5a72847430dc58f71	1532	MobiDBLite	mobidb-lite	consensus disorder prediction	1433	1463	-	T	24-06-2023	-	-
NZ_CP009512.1_orf64386	b3daada1756e28a5a72847430dc58f71	1532	CDD	cd10150	CobN_like	220	1251	0.0	T	24-06-2023	IPR003672	CobN/magnesium chelatase
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	MobiDBLite	mobidb-lite	consensus disorder prediction	1701	1722	-	T	24-06-2023	-	-
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	FunFam	G3DSA:3.40.50.300:FF:002475	DNA helicase related protein	269	475	2.2E-105	T	24-06-2023	-	-
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	Pfam	PF13195	Protein of unknown function (DUF4011)	27	213	2.5E-42	T	24-06-2023	IPR025103	Uncharacterized ATP-dependent helicase MG140
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	Pfam	PF18741	REase_MTES_1575	1278	1374	1.2E-35	T	24-06-2023	-	-
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	Gene3D	G3DSA:3.40.960.10	VSR Endonuclease	1274	1382	7.8E-16	T	24-06-2023	-	-
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	Pfam	PF13086	AAA domain	973	1013	3.2E-6	T	24-06-2023	IPR041677	DNA2/NAM7 helicase, helicase domain
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	CDD	cd18808	SF1_C_Upf1	1060	1260	9.79265E-26	T	24-06-2023	IPR047187	Upf1-like, C-terminal helicase domain
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	Coils	Coil	Coil	424	447	-	T	24-06-2023	-	-
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	MobiDBLite	mobidb-lite	consensus disorder prediction	1487	1512	-	T	24-06-2023	-	-
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	PANTHER	PTHR10887	DNA2/NAM7 HELICASE FAMILY	270	1236	5.5E-34	T	24-06-2023	IPR045055	DNA2/NAM7-like helicase
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	SMART	SM00952	RAP_3	1321	1378	2.4E-4	T	24-06-2023	IPR013584	RAP domain
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	Pfam	PF11784	Protein of unknown function (DUF3320)	1748	1795	5.2E-10	T	24-06-2023	IPR021754	Domain of unknown function DUF3320
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	FunFam	G3DSA:3.40.960.10:FF:000002	DNA helicase related protein	1274	1379	2.0E-50	T	24-06-2023	-	-
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	Gene3D	G3DSA:3.40.50.300	-	269	479	2.3E-19	T	24-06-2023	IPR027417	P-loop containing nucleoside triphosphate hydrolase
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	Gene3D	G3DSA:3.40.50.300	-	856	1031	5.0E-13	T	24-06-2023	IPR027417	P-loop containing nucleoside triphosphate hydrolase
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	SUPERFAMILY	SSF52540	P-loop containing nucleoside triphosphate hydrolases	323	1258	4.86E-40	T	24-06-2023	IPR027417	P-loop containing nucleoside triphosphate hydrolase
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	Pfam	PF13087	AAA domain	1047	1233	5.2E-13	T	24-06-2023	IPR041679	DNA2/NAM7 helicase-like, C-terminal
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	MobiDBLite	mobidb-lite	consensus disorder prediction	72	95	-	T	24-06-2023	-	-
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	SUPERFAMILY	SSF52980	Restriction endonuclease-like	1273	1390	3.59E-18	T	24-06-2023	IPR011335	Restriction endonuclease  type II-like
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	MobiDBLite	mobidb-lite	consensus disorder prediction	1544	1581	-	T	24-06-2023	-	-
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	MobiDBLite	mobidb-lite	consensus disorder prediction	1631	1645	-	T	24-06-2023	-	-
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	MobiDBLite	mobidb-lite	consensus disorder prediction	1680	1722	-	T	24-06-2023	-	-
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	MobiDBLite	mobidb-lite	consensus disorder prediction	1628	1647	-	T	24-06-2023	-	-
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	FunFam	G3DSA:3.40.50.300:FF:002063	DNA helicase related protein	1059	1260	1.8E-92	T	24-06-2023	-	-
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	MobiDBLite	mobidb-lite	consensus disorder prediction	1563	1579	-	T	24-06-2023	-	-
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	MobiDBLite	mobidb-lite	consensus disorder prediction	1473	1512	-	T	24-06-2023	-	-
NZ_CP009512.1_orf80716	981f2a1db5e0d8ecfa789a1d0c1618a3	1911	Gene3D	G3DSA:3.40.50.300	-	1059	1245	1.4E-25	T	24-06-2023	IPR027417	P-loop containing nucleoside triphosphate hydrolase
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	391	424	11.092401	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	629	662	11.210401	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	459	492	11.416901	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	765	798	9.2634	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	85	118	9.4994	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	663	696	9.6764	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	PANTHER	PTHR44943	CELLULOSE SYNTHASE OPERON PROTEIN C	290	392	0.0	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	255	288	11.8889	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50293	TPR repeat region circular profile.	1133	1165	8.755289	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Gene3D	G3DSA:1.25.40.10	Tetratricopeptide repeat domain	1293	1435	2.2E-25	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SUPERFAMILY	SSF48452	TPR-like	1540	1822	9.1E-54	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	1781	1814	8.5554	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Gene3D	G3DSA:1.25.40.10	Tetratricopeptide repeat domain	1539	1642	1.7E-25	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Gene3D	G3DSA:1.25.40.10	Tetratricopeptide repeat domain	593	694	5.7E-25	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Gene3D	G3DSA:1.25.40.10	Tetratricopeptide repeat domain	695	794	1.9E-20	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	1611	1644	11.062901	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	952	985	10.1779	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	1438	1471	11.151401	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	561	594	10.6499	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Gene3D	G3DSA:1.25.40.10	Tetratricopeptide repeat domain	285	381	7.0E-24	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Gene3D	G3DSA:1.25.40.10	Tetratricopeptide repeat domain	795	876	5.9E-15	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	1747	1780	12.8329	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SUPERFAMILY	SSF48439	Protein prenylyltransferase	1058	1385	2.88E-46	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	493	526	11.534901	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	357	390	11.210401	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50293	TPR repeat region circular profile.	493	524	9.462682	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SUPERFAMILY	SSF48452	TPR-like	360	572	3.34E-55	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50293	TPR repeat region circular profile.	255	288	9.294255	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF13414	TPR repeat	1140	1181	5.2E-7	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SUPERFAMILY	SSF48452	TPR-like	24	355	8.35E-62	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	1543	1576	9.9124	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Gene3D	G3DSA:1.25.40.10	Tetratricopeptide repeat domain	382	451	1.8E-13	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	1167	1200	8.5259	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	MobiDBLite	mobidb-lite	consensus disorder prediction	1271	1290	-	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	1065	1098	10.7974	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	874	907	73.0	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1577	1610	6.7E-4	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	989	1022	0.0034	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1404	1437	0.03	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1472	1505	0.4	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	833	866	15.0	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1543	1576	0.52	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	952	985	5.0E-5	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	799	832	0.0025	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1065	1098	0.029	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	255	288	6.3E-5	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	323	356	4.7	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	918	951	75.0	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	459	492	4.2E-4	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	663	696	0.69	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	85	118	0.003	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1506	1539	0.02	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1329	1362	14.0	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	527	560	1.1E-4	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	629	662	0.041	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	187	220	0.0021	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	595	628	2.6E-5	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1781	1814	0.067	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1747	1780	2.7E-4	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	697	730	0.0024	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1133	1166	7.3E-4	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	425	458	0.051	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	765	798	0.22	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	119	152	0.0015	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1679	1712	0.23	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	153	186	3.4E-7	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	561	594	1.3E-4	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1031	1064	19.0	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	391	424	0.021	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	17	50	2.4	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1167	1200	35.0	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1099	1132	9.7	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1611	1644	1.0E-4	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1713	1746	0.027	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	357	390	0.0018	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	731	764	18.0	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1363	1396	47.0	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1235	1268	18.0	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1645	1678	0.23	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	493	526	6.7E-5	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	1438	1471	0.05	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	51	84	9.8E-5	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00028	tpr_5	289	322	1.9E-4	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	153	186	13.5999	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	1329	1362	9.6469	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	1363	1396	8.4374	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	1679	1712	9.2929	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00386	hat_new_1	337	369	180.0	T	24-06-2023	IPR003107	HAT (Half-A-TPR) repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00386	hat_new_1	1147	1181	370.0	T	24-06-2023	IPR003107	HAT (Half-A-TPR) repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00386	hat_new_1	899	932	900.0	T	24-06-2023	IPR003107	HAT (Half-A-TPR) repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00386	hat_new_1	1591	1625	98.0	T	24-06-2023	IPR003107	HAT (Half-A-TPR) repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00386	hat_new_1	677	709	510.0	T	24-06-2023	IPR003107	HAT (Half-A-TPR) repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00386	hat_new_1	1501	1531	1200.0	T	24-06-2023	IPR003107	HAT (Half-A-TPR) repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00386	hat_new_1	1452	1491	940.0	T	24-06-2023	IPR003107	HAT (Half-A-TPR) repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00386	hat_new_1	1003	1039	1200.0	T	24-06-2023	IPR003107	HAT (Half-A-TPR) repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00386	hat_new_1	643	675	330.0	T	24-06-2023	IPR003107	HAT (Half-A-TPR) repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00386	hat_new_1	1418	1450	32.0	T	24-06-2023	IPR003107	HAT (Half-A-TPR) repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00386	hat_new_1	31	65	400.0	T	24-06-2023	IPR003107	HAT (Half-A-TPR) repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SMART	SM00386	hat_new_1	371	403	880.0	T	24-06-2023	IPR003107	HAT (Half-A-TPR) repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	697	730	8.6734	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50293	TPR repeat region circular profile.	989	1021	8.519491	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF00515	Tetratricopeptide repeat	153	186	4.0E-8	T	24-06-2023	IPR001440	Tetratricopeptide repeat 1
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF00515	Tetratricopeptide repeat	529	560	8.1E-7	T	24-06-2023	IPR001440	Tetratricopeptide repeat 1
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Gene3D	G3DSA:1.25.40.10	Tetratricopeptide repeat domain	1025	1274	3.0E-45	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50293	TPR repeat region circular profile.	1577	1610	9.732164	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	187	220	9.1159	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Gene3D	G3DSA:1.25.40.10	Tetratricopeptide repeat domain	188	284	9.0E-18	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SUPERFAMILY	SSF48452	TPR-like	1295	1611	1.9E-47	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	595	628	10.3549	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	425	458	9.2044	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	1577	1610	11.475901	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SUPERFAMILY	SSF48452	TPR-like	529	765	8.72E-57	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50293	TPR repeat region circular profile.	153	186	10.338501	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50293	TPR repeat region circular profile.	1747	1780	10.136389	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	17	50	8.5849	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Gene3D	G3DSA:1.25.40.10	Tetratricopeptide repeat domain	122	187	7.1E-17	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF13432	Tetratricopeptide repeat	742	796	5.8E-7	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF13432	Tetratricopeptide repeat	361	410	9.5E-7	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF13432	Tetratricopeptide repeat	1410	1470	8.4E-7	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF13432	Tetratricopeptide repeat	265	321	1.4E-7	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF13432	Tetratricopeptide repeat	1753	1814	2.0E-8	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF13432	Tetratricopeptide repeat	95	148	0.0031	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF13432	Tetratricopeptide repeat	22	84	2.0E-7	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF13432	Tetratricopeptide repeat	599	661	1.4E-7	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF13432	Tetratricopeptide repeat	1581	1639	3.9E-10	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF13432	Tetratricopeptide repeat	669	729	1.7E-9	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF13432	Tetratricopeptide repeat	1035	1096	2.6E-4	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF13432	Tetratricopeptide repeat	1694	1743	3.1E-5	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF13432	Tetratricopeptide repeat	1301	1361	0.0048	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Gene3D	G3DSA:1.25.40.10	Tetratricopeptide repeat domain	16	121	4.6E-25	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	51	84	10.7089	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Gene3D	G3DSA:1.25.40.10	Tetratricopeptide repeat domain	452	592	1.3E-38	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Gene3D	G3DSA:1.25.40.10	Tetratricopeptide repeat domain	1643	1833	1.5E-43	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50293	TPR repeat region circular profile.	289	321	8.586863	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	SUPERFAMILY	SSF48452	TPR-like	766	1024	1.4E-52	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF07719	Tetratricopeptide repeat	990	1021	1.5E-5	T	24-06-2023	IPR013105	Tetratricopeptide repeat 2
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Gene3D	G3DSA:1.25.40.10	Tetratricopeptide repeat domain	877	1024	2.7E-26	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF12895	Anaphase-promoting complex, cyclosome, subunit 3	888	977	5.0E-8	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF12895	Anaphase-promoting complex, cyclosome, subunit 3	440	518	5.6E-8	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	527	560	10.3254	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF13181	Tetratricopeptide repeat	1544	1576	0.05	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF13181	Tetratricopeptide repeat	1364	1390	0.083	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF13181	Tetratricopeptide repeat	188	218	0.074	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	1404	1437	10.2959	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	1645	1678	9.4994	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Gene3D	G3DSA:1.25.40.10	Tetratricopeptide repeat domain	1436	1538	3.9E-21	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50293	TPR repeat region circular profile.	391	423	8.890031	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	918	951	8.5849	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	799	832	9.9124	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	1713	1746	9.9419	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	989	1022	11.151401	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	119	152	10.3254	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	1133	1166	10.944901	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF14559	Tetratricopeptide repeat	809	865	3.6E-8	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	Pfam	PF14559	Tetratricopeptide repeat	1487	1543	3.8E-6	T	24-06-2023	-	-
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	289	322	11.298901	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf99807	dc483ca7efb3be3bddf040c7402e2ece	1834	ProSiteProfiles	PS50005	TPR repeat profile.	1472	1505	8.2014	T	24-06-2023	IPR019734	Tetratricopeptide repeat
NZ_CP009512.1_orf25685	578300d615f73d537b1741afac50cf0c	1645	Gene3D	G3DSA:3.40.50.300	-	252	424	3.5E-33	T	24-06-2023	IPR027417	P-loop containing nucleoside triphosphate hydrolase
NZ_CP009512.1_orf25685	578300d615f73d537b1741afac50cf0c	1645	Gene3D	G3DSA:1.25.40.370	-	616	706	2.7E-5	T	24-06-2023	-	-
NZ_CP009512.1_orf25685	578300d615f73d537b1741afac50cf0c	1645	Gene3D	G3DSA:1.25.40.10	Tetratricopeptide repeat domain	1183	1296	2.5E-10	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf25685	578300d615f73d537b1741afac50cf0c	1645	Gene3D	G3DSA:1.25.40.10	Tetratricopeptide repeat domain	747	860	1.2E-5	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf25685	578300d615f73d537b1741afac50cf0c	1645	Gene3D	G3DSA:1.25.40.10	Tetratricopeptide repeat domain	1003	1115	7.5E-8	T	24-06-2023	IPR011990	Tetratricopeptide-like helical domain superfamily
NZ_CP009512.1_orf25685	578300d615f73d537b1741afac50cf0c	1645	Coils	Coil	Coil	1226	1246	-	T	24-06-2023	-	-
NZ_CP009512.1_orf25685	578300d615f73d537b1741afac50cf0c	1645	Gene3D	G3DSA:1.10.10.10	-	508	597	5.2E-16	T	24-06-2023	IPR036388	Winged helix-like DNA-binding domain superfamily
NZ_CP009512.1_orf25685	578300d615f73d537b1741afac50cf0c	1645	SUPERFAMILY	SSF48371	ARM repeat	800	1573	3.01E-14	T	24-06-2023	IPR016024	Armadillo-type fold
NZ_CP009512.1_orf25685	578300d615f73d537b1741afac50cf0c	1645	Pfam	PF00931	NB-ARC domain	277	487	9.0E-23	T	24-06-2023	IPR002182	NB-ARC
NZ_CP009512.1_orf25685	578300d615f73d537b1741afac50cf0c	1645	Pfam	PF17908	APAF-1 helical domain	618	669	2.6E-5	T	24-06-2023	IPR041452	APAF-1 helical domain
NZ_CP009512.1_orf25685	578300d615f73d537b1741afac50cf0c	1645	PANTHER	PTHR36766	PLANT BROAD-SPECTRUM MILDEW RESISTANCE PROTEIN RPW8	186	601	5.6E-36	T	24-06-2023	IPR039203	Disease resistance protein, RPW8-like
NZ_CP009512.1_orf25685	578300d615f73d537b1741afac50cf0c	1645	SUPERFAMILY	SSF52540	P-loop containing nucleoside triphosphate hydrolases	262	519	3.56E-35	T	24-06-2023	IPR027417	P-loop containing nucleoside triphosphate hydrolase
NZ_CP009512.1_orf25685	578300d615f73d537b1741afac50cf0c	1645	PRINTS	PR00364	Disease resistance protein signature	296	311	4.2E-9	T	24-06-2023	-	-
NZ_CP009512.1_orf25685	578300d615f73d537b1741afac50cf0c	1645	PRINTS	PR00364	Disease resistance protein signature	370	384	4.2E-9	T	24-06-2023	-	-
NZ_CP009512.1_orf25685	578300d615f73d537b1741afac50cf0c	1645	PRINTS	PR00364	Disease resistance protein signature	456	470	4.2E-9	T	24-06-2023	-	-
NZ_CP009512.1_orf25685	578300d615f73d537b1741afac50cf0c	1645	Coils	Coil	Coil	93	113	-	T	24-06-2023	-	-
